BIYKEM BOZKURT to Biphenyl Compounds
This is a "connection" page, showing publications BIYKEM BOZKURT has written about Biphenyl Compounds.
Connection Strength
0.962
-
Ten years real-world experience with sacubitril/valsartan in patients with heart failure with reduced ejection fraction. ESC Heart Fail. 2026 Mar 03; 13(2).
Score: 0.232
-
Mortality, Outcomes, Costs, and Use of?Medicines Following a First Heart?Failure?Hospitalization: EVOLUTION HF. JACC Heart Fail. 2023 10; 11(10):1320-1332.
Score: 0.192
-
Heart?Failure Drug Treatment-Inertia,?Titration, and Discontinuation: A Multinational Observational Study (EVOLUTION HF). JACC Heart Fail. 2023 01; 11(1):1-14.
Score: 0.182
-
Ins and Outs: Perspectives of Inpatient Prescribing for Sacubitril/Valsartan. Ann Pharmacother. 2021 06; 55(6):805-813.
Score: 0.160
-
Substance and Substrate: LVEF and Sex Subgroup Analyses of PARAGON-HF and PARADIGM-HF Trials. Circulation. 2020 02 04; 141(5):362-366.
Score: 0.152
-
The year in cardiovascular medicine 2021: heart failure and cardiomyopathies. Eur Heart J. 2022 Feb 03; 43(5):367-376.
Score: 0.044